Infectious Enteritis Treatment Market Share

Market Share of Infectious Enteritis Treatment Industry

The infectious enteritis treatment market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known, including Actelion Pharmaceuticals, BioGaia, Bristol-Myers Squibb, GlaxoSmithKline plc, Mayne Pharma, Novartis Pharmaceuticals, Pfizer Inc., Teva Pharmaceuticals, among others.

Infectious Enteritis Treatment Market Leaders

1. Novartis Pharmaceuticals

2. Teva Pharmaceuticals

3. Pfizer Inc.

4. GlaxoSmithKline plc.

5. Mayne Pharma

*Disclaimer: Major Players sorted in no particular order